Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review (Q37713670)

22 August 2017

1 reference

title

Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review (English)

1 reference

22 August 2017

1 reference

Cesare Turrina

2

0 references

Emilio Sacchetti

object named as

Emilio Sacchetti

series ordinal

1

0 references

author name string

Paolo Valsecchi

series ordinal

3

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

33

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

273-288

1 reference

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

Conventional vs. newer antipsychotics in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

Mortality in elderly Canadians with and without dementia: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11319120-000000000-00000

Altered lipid metabolism in brain injury and disorders

21 January 2018

1 reference

12 December 2020

Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease

1 reference

12 December 2020

Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial

1 reference

12 December 2020

Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users

1 reference

12 December 2020

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology

1 reference

12 December 2020

Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year

1 reference

12 December 2020

Massive pulmonary embolism in a young patient on clozapine therapy

1 reference

12 December 2020

Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study

1 reference

12 December 2020

The neuroprotective effect of olanzapine

1 reference

12 December 2020

Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.

1 reference

12 December 2020

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics

1 reference

12 December 2020

Nicotine and familial vulnerability to schizophrenia: a discordant twin study

1 reference

12 December 2020

A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families

1 reference

12 December 2020

Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone

1 reference

12 December 2020

Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

1 reference

12 December 2020

Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly

1 reference

12 December 2020

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

1 reference

12 December 2020

Family history of type 2 diabetes in schizophrenic patients

1 reference

12 December 2020

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

1 reference

12 December 2020

Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al

1 reference

12 December 2020

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

1 reference

12 December 2020

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics

1 reference

12 December 2020

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

12 December 2020

Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole

1 reference

12 December 2020

Risk of cerebrovascular events in elderly users of antipsychotics

1 reference

12 December 2020

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

1 reference

12 December 2020

A prototypical Sigma-1 receptor antagonist protects against brain ischemia

1 reference

12 December 2020

Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia

1 reference

12 December 2020

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

1 reference

12 December 2020

Exposure to antipsychotics and risk of stroke: self controlled case series study

1 reference

12 December 2020

Olanzapine attenuates brain damage after focal cerebral ischemia in vivo

1 reference

12 December 2020

Atypical antipsychotics and risk of cerebrovascular accidents.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease

1 reference

12 December 2020

Do atypical antipsychotics cause stroke?

1 reference

12 December 2020

A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia

1 reference

12 December 2020

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

1 reference

12 December 2020

Mortality of hospitalized psychiatric patients--results of a 10-year study

1 reference

12 December 2020

Mortality in the long-stay population of Dutch mental hospitals

1 reference

12 December 2020

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

1 reference

12 December 2020

Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study

1 reference

12 December 2020

Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients

1 reference

12 December 2020

Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia

1 reference

12 December 2020

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Antipsychotic-induced venous thromboembolism: a review of the evidence

1 reference

12 December 2020

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

1 reference

12 December 2020

The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.

1 reference

12 December 2020

Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register

1 reference

12 December 2020

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

1 reference

12 December 2020

Role of inflammation in stroke and atherothrombosis

1 reference

12 December 2020

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

1 reference

12 December 2020

Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients

1 reference

12 December 2020

A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia

1 reference

12 December 2020

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy

1 reference

12 December 2020

Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects

1 reference

12 December 2020

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

12 December 2020

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses

1 reference

12 December 2020

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

1 reference

12 December 2020

Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996

1 reference

12 December 2020

Using antipsychotic agents in older patients

1 reference

12 December 2020

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial

1 reference

12 December 2020

Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial

1 reference

12 December 2020

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents

1 reference

12 December 2020

Influence of pre-existing dementia on the risk of post-stroke epileptic seizures.

1 reference

12 December 2020

A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial

1 reference

12 December 2020

Risperidone attenuates brain damage after focal cerebral ischemia in vivo

1 reference

12 December 2020

Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions

1 reference

12 December 2020

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

1 reference

12 December 2020

10.2165/11319120-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1048703620

0 references

1 reference